World Without Disease Accelerator
Our mission
Consistent with Johnson & Johnson’s transformational medical innovation strategy, the mission of the World Without Disease Accelerator (WWDA) is to discover, develop and prepare for the commercialization of disruptive products, solutions and technologies focused on the interception of disease.
Our approach
The WWDA is an enterprise R&D group aligned with global commercial expertise that brings together unique capabilities, business models and partnerships to advance its mission of intercepting disease. Such capabilities span areas like the microbiome, immunosciences, predictive analytics and behavioral science to seed and catalyze a paradigm shift in healthcare through disease interception strategies and solutions.
Consistent with Johnson & Johnson’s transformational medical innovation strategy, the mission of the World Without Disease Accelerator (WWDA) is to discover, develop and prepare for the commercialization of disruptive products, solutions and technologies focused on the interception of disease.
Our approach
The WWDA is an enterprise R&D group aligned with global commercial expertise that brings together unique capabilities, business models and partnerships to advance its mission of intercepting disease. Such capabilities span areas like the microbiome, immunosciences, predictive analytics and behavioral science to seed and catalyze a paradigm shift in healthcare through disease interception strategies and solutions.
We envision a world in which disease is a historical artifact
Related Stories
The Microbiome: Today’s Promising Science, Tomorrow’s Health Solutions
Our leadership team
The WWDA leadership team, a diverse group of experts globally situated within Janssen and Johnson & Johnson Innovation locations, is united by one vision: to lead a new paradigm in health care through the interception of disease.